2.54 USD
▲+0.11+9.01%
盘后 2.37 +1.72%
2026-08-03
市值
$474.07M
市盈率
—
EPS
-0.27
股息率
—
52 周区间
0.48 – 3.11
成交量
1.67M
Beta
0.23
目标价
5.69
52W 低 0.4852W 高 3.11
价格走势
公司简介
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's d...